John Bondo Hansen, Founder, CEO
John Bondo Hansen is Ph.D. in medicinal chemistry and has more 30 years’ experience in drug discovery.
From 2002 to 2008 he served as vice president at Novo Nordisk.
From 2007 to 2014 he has been board director of Aurigene Discovery Technologies (India) and from 2008 to 2010 he was co-founder and CSO of Sound Biotech.
He is founder of Konticon Consulting in 2008 and has been consultant for different companies and organizations.
He has published more than 120 scientific papers and patents. He has taken a number of projects from discovery to development primarily with metabolic disorders and CNS diseases.
Mikael Thomsen, Founder, CSO
Mikael Thomsen is Ph.D. in Pharmacology & Toxicology, with 20 years of experience from FDA, Novartis, Novo Nordisk, and several European Biotechs.
He has co-founded Prosidion Ltd. and Sound Biotech.
In all these companies, he has managed all the activities necessary for taking a compound from late Discovery to Phase II/cPoC.
Mikael is a strong advocate for accelerated drug development. He was 2010-2012 CSO of Bridge BioResearch.
He has authored or co-authored more than 50 publications and abstracts.
Board of Directors
Sang-Hoon Kim, Co-presidents & CEO
Hee-Won Yoo, PhD, Co-presidents & CEO
Peter G. Nielsen, MSc
Mads Kreilgaard, PhD